292 related articles for article (PubMed ID: 31904558)
1. Construction of a core-shell microneedle system to achieve targeted co-delivery of checkpoint inhibitors for melanoma immunotherapy.
Yang P; Lu C; Qin W; Chen M; Quan G; Liu H; Wang L; Bai X; Pan X; Wu C
Acta Biomater; 2020 Mar; 104():147-157. PubMed ID: 31904558
[TBL] [Abstract][Full Text] [Related]
2. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
Han X; Li H; Zhou D; Chen Z; Gu Z
Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle-integrated dissolving microneedles for the co-delivery of R848/aPD-1 to synergistically reverse the immunosuppressive microenvironment of triple-negative breast cancer.
Huang S; Wen T; Wang J; Wei H; Xiao Z; Li B; Shuai X
Acta Biomater; 2024 Mar; 176():344-355. PubMed ID: 38244662
[TBL] [Abstract][Full Text] [Related]
4. Cold to Hot: Binary Cooperative Microneedle Array-Amplified Photoimmunotherapy for Eliciting Antitumor Immunity and the Abscopal Effect.
Chen M; Quan G; Wen T; Yang P; Qin W; Mai H; Sun Y; Lu C; Pan X; Wu C
ACS Appl Mater Interfaces; 2020 Jul; 12(29):32259-32269. PubMed ID: 32406239
[TBL] [Abstract][Full Text] [Related]
5. Microneedles loaded with anti-PD-1-cisplatin nanoparticles for synergistic cancer immuno-chemotherapy.
Lan X; Zhu W; Huang X; Yu Y; Xiao H; Jin L; Pu JJ; Xie X; She J; Lui VWY; Chen HJ; Su YX
Nanoscale; 2020 Sep; 12(36):18885-18898. PubMed ID: 32902555
[TBL] [Abstract][Full Text] [Related]
6. Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy.
Li L; Miao Q; Meng F; Li B; Xue T; Fang T; Zhang Z; Zhang J; Ye X; Kang Y; Zhang X; Chen Q; Liang X; Chen H; Zhang X
Theranostics; 2021; 11(12):6033-6043. PubMed ID: 33897897
[TBL] [Abstract][Full Text] [Related]
7. Derma roller® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect.
Ahmed KS; Shan X; Mao J; Qiu L; Chen J
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1448-1458. PubMed ID: 30889679
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Delivery of Checkpoint Inhibitors.
Ye Y; Wang J; Hu Q; Hochu GM; Xin H; Wang C; Gu Z
ACS Nano; 2016 Sep; 10(9):8956-63. PubMed ID: 27599066
[TBL] [Abstract][Full Text] [Related]
9. Tumor acidity-activatable macromolecule autophagy inhibitor and immune checkpoint blockade for robust treatment of prostate cancer.
Wang Y; Lei H; Yan B; Zhang S; Xu B; Lin M; Shuai X; Huang J; Pang J
Acta Biomater; 2023 Sep; 168():593-605. PubMed ID: 37474083
[TBL] [Abstract][Full Text] [Related]
10. Chitosan microneedle patches for sustained transdermal delivery of macromolecules.
Chen MC; Ling MH; Lai KY; Pramudityo E
Biomacromolecules; 2012 Dec; 13(12):4022-31. PubMed ID: 23116140
[TBL] [Abstract][Full Text] [Related]
11. [Preparation and evaluation of chitosan-based light source-loaded soluble microneedles].
Liu F; Zhuang J; Xue Q; Xu H; Huang Y; Sun J; Zhang X; Li M
Sheng Wu Gong Cheng Xue Bao; 2024 Feb; 40(2):562-572. PubMed ID: 38369841
[TBL] [Abstract][Full Text] [Related]
12. AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.
Strecker MI; Wlotzka K; Strassheimer F; Roller B; Ludmirski G; König S; Röder J; Opitz C; Alekseeva T; Reul J; Sevenich L; Tonn T; Wels WS; Steinbach JP; Buchholz CJ; Burger MC
Oncoimmunology; 2022; 11(1):2127508. PubMed ID: 36249274
[TBL] [Abstract][Full Text] [Related]
13. Microneedle-Assisted Topical Delivery of Photodynamically Active Mesoporous Formulation for Combination Therapy of Deep-Seated Melanoma.
Tham HP; Xu K; Lim WQ; Chen H; Zheng M; Thng TGS; Venkatraman SS; Xu C; Zhao Y
ACS Nano; 2018 Dec; 12(12):11936-11948. PubMed ID: 30444343
[TBL] [Abstract][Full Text] [Related]
14. Sustained antigens delivery using composite microneedles for effective epicutaneous immunotherapy.
Zhang E; Zeng B; Song R; Yao L; Che H
Drug Deliv Transl Res; 2023 Jun; 13(6):1828-1841. PubMed ID: 36964440
[TBL] [Abstract][Full Text] [Related]
15. Dissolving microneedles-based programmed delivery system for enhanced chemo-immunotherapy of melanoma.
Tian Y; Jing H; Wang Q; Hu S; Wu Z; Duan Y
J Control Release; 2023 Aug; 360():630-646. PubMed ID: 37414221
[TBL] [Abstract][Full Text] [Related]
16. Dissolvable Self-Locking Microneedle Patches Integrated with Immunomodulators for Cancer Immunotherapy.
Joo SH; Kim J; Hong J; Fakhraei Lahiji S; Kim YH
Adv Mater; 2023 Mar; 35(10):e2209966. PubMed ID: 36528846
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-Mediated Delivery of Inhaled Immunotherapeutics for Treating Lung Metastasis.
Jin Q; Zhu W; Zhu J; Zhu J; Shen J; Liu Z; Yang Y; Chen Q
Adv Mater; 2021 Feb; 33(7):e2007557. PubMed ID: 33448035
[TBL] [Abstract][Full Text] [Related]
18. Built-In Active Microneedle Patch with Enhanced Autonomous Drug Delivery.
Lopez-Ramirez MA; Soto F; Wang C; Rueda R; Shukla S; Silva-Lopez C; Kupor D; McBride DA; Pokorski JK; Nourhani A; Steinmetz NF; Shah NJ; Wang J
Adv Mater; 2020 Jan; 32(1):e1905740. PubMed ID: 31682039
[TBL] [Abstract][Full Text] [Related]
19. Tip-loaded fast-dissolving microneedle patches for photodynamic therapy of subcutaneous tumor.
Zhao X; Li X; Zhang P; Du J; Wang Y
J Control Release; 2018 Sep; 286():201-209. PubMed ID: 30056119
[TBL] [Abstract][Full Text] [Related]
20. Tip-loaded dissolving microneedles for transdermal delivery of donepezil hydrochloride for treatment of Alzheimer's disease.
Kim JY; Han MR; Kim YH; Shin SW; Nam SY; Park JH
Eur J Pharm Biopharm; 2016 Aug; 105():148-55. PubMed ID: 27288938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
